New Challenges in Vaccine Production During Global Pandemics

Posted on

by Nelson Landrau, CEO/Founder; Malcolm G. Pluskal, PhD. This article was published by the North Central Massachusetts Chamber of Commerce in their Guest Columnist series. Massachusetts has encouraged and supported Biopharmaceutical R&D and large-scale Biologics manufacturing throughout the last 30+ years and has become one of the world leaders in development of new technology platforms. […]